Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

US Patent 12357586 · Granted Jul 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cannabinoid derivatives as pharmaceutically active compounds and methods of prep2025
Cannabidiol-type cannabinoid compound2025
Cannabidiol-type cannabinoid compound2025
Cannabidiol-type cannabinoid compound2025
Use of cannabinoids in the treatment of dyskinesia associated with parkinson's d2025
Use of cannabidiol in the treatment of tuberous sclerosis complex2025
Use of cannabidiol in the treatment of tuberous sclerosis complex2025
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy2024
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy2024